From: Increased serum asprosin is correlated with diabetes mellitus-induced erectile dysfunction
NC(n = 45) | DM(n = 45) | DMED(n = 45) | P | |
---|---|---|---|---|
Age (years) | 51.00 (48.00,50.00) | 55.00(47.50,61.00) | 56.00(47.00,62.00) | 0.342 |
WC (cm) | 79.91 ± 1.18 | 84.75 ± 1.04a | 85.62 ± 0.01a | p < 0.001 |
WHR | 0.81 ± 0.01 | 0.85 ± 0.01a | 0.87 ± 0.02ab | p < 0.001 |
BMI(kg/m2) | 22.62 ± 0.29 | 24.17 ± 0.30a | 25.44 ± 0.43ab | p < 0.001 |
Smoking, current/past (n,%) | 4(8.89%) | 16(35.56%) | 17(37.78%) | 0.844 |
alcoholic(n,%) | 9(20%) | 9(20%) | 12(26.67%) | 0.680 |
Duration of DM (years) | - | 5.00(3.00,8.00) | 8.00(4.50,9.50)b | 0.003 |
SBP (mmHg) | 124.33 ± 1.78 | 127.96 ± 1.81 | 127.73 ± 2.43 | 0.370 |
DBP (mmHg) | 78.29 ± 1.35 | 81.69 ± 1.08 | 81.02 ± 1.50 | 0.160 |
Treatment | ||||
Statin (n, %) | 4(4.89%) | 12(26.67%)a | 13(28.89%)a | 0.041 |
Metformin (n, %) | - | 18(40.00%) | 23(51.1%) | 0.290 |
Sulfonylureas (n, %) | - | 10(22.22%) | 11(24.4%) | 0.803 |
DPP-IV i (n, %) | - | 7(15.56%) | 8(17.78%) | 0.777 |
GLP-1RA(n,%) | - | 9(20.0%) | 10(22.22%) | 0.796 |
SGLT2i(n,%) | - | 12(26.67%) | 13(28.89%) | 0.814 |
Acarbose (n, %) | - | 18(40.0%) | 17(37.78%) | 0.829 |
Insulin (n, %) | - | 15(33.33%) | 17(37.78%) | 0.660 |
TZDs(n, %) | - | 4(4.89%) | 5(11.11%) | 0.725 |
ACEI/ARB(n,%) | 5(11.11%) | 5(11.11%) | 6(13.33%) | 0.932 |
CCB(n,%) | 3(6.67%) | 4(8.89%) | 6(13.33%) | 0.551 |
β-blocker(n,%) | 3(6.67%) | 2(4.44%) | 3(6.67%) | 0.876 |
diuretic(n,%) | 2(4.44%) | 2(4.44%) | 1(2.22%) | 0.812 |